Helicobacter typhlonius

Last updated

Helicobacter typhlonius
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Bacteria
Phylum: Campylobacterota
Class: "Campylobacteria"
Order: Campylobacterales
Family: Helicobacteraceae
Genus: Helicobacter
Species:
H. typhlonius
Binomial name
Helicobacter typhlonius
Franklin et al. 2001

Helicobacter typhlonius is a Gram-negative bacterium and opportunistic pathogen found in the genus Helicobacter . [1] Only 35 known species are in this genus, which was described in 1982. [2] [1] H. typhlonius has a small number of close relatives, including Helicobacter muridarum, Helicobacter trogontum , and Helicobacter hepaticus , with the latter being the closest relative and much more prevalent. [1]

Contents

Taxonomy

Helicobacter typhlonius is one of 35 known species of Helicobacter. [2] It was previously named Helicobacter sp. strain MIT 97-6910 by Fox et al., but was changed to its current name by Franklin et al. after discovering a genetically and morphologically identical organism that causes proliferative typhlocolitis, also known as irritable bowel disease. [3] [1] Some close relatives of H. typhlonius include H. muridarum, H. trogontum, H. hepaticus, and H. pylori. [1]

Morphology and physiology

Helicobacter typhlonius is motile due to its single sheathed flagellum. [1] It has a spiral morphology, and its size is 0.3 by 2.0 to 3.0 μm. [1] It is capable of ammonia assimilation, urea production, and phosphoribosyl pyrophosphate biosynthesis. [1] H. typhlonius is also urease-negative, which is known to assist in survival and proliferation of microbes in acidic gastric environments. [1] Additionally, it can only grow in microaerobic conditions (a very small amount of oxygen), not in aerobic or anaerobic conditions. [1]

Discovery

Helicobacter typhlonius was isolated from the feces of immunocompromised mice by James G. Fox and Craig L. Franklin in two separate laboratories in 1999. [4] The mice suffered from irritable bowel syndrome, which was caused by H. typhlonius, but the mechanism of the infection was unknown. [1] Polymerase chain reaction (PCR) was used to copy the DNA sequence of the bacteria to be examined. [1] PCR was an ideal method, due to the unique intervening genome sequence that is easily recognized by PCR. [5] The sequences were then analyzed using the Sequence Analysis Software Package (Wisconsin Package, version 10.0; Genetics Computer Group, Inc., Madison Wis.). [1] The biochemical results of PCR tests, as well as phenotypic test results of all other 32 known species of Helicobacter, were compared to the results given by the newly isolated species. [1] After observing the results and declaring H. typhlonius a new species of Helicobacter, a new phylogenetic tree for the genus Helicobacter was created. [1]

Genomics

The full genome was determined using single-molecule, real-time sequencing in 2015 by Frank et al. Using hierarchical genome assembly process, the sequences were assembled into a single long read. [2]

The genome of H. typhlonius is 1,920,000 base pairs in length, [2] with 2,117 protein-coding genes and 43 RNA genes with a GC-content of 38.8%. [2] Compared to other members of the genus Helicobacter such as H. hepaticus and H. pylori, H. typhlonius has a larger genome. [2] Furthermore, H. typhlonius has a GC-content that is similar to H. hepaticus. [2] While roughly 75% of protein-coding genes were shared between H. hepaticus and H. typhlonius, 468 unique protein-coding genes were identified in H. typhlonius, which comprise about 2% of its entire genome. [2]

Additionally, the genome contains a distinct pathogenicity island with a lower GC-content and flanked by repeats. [2] This island is around 650,000 base pairs and compromises 75 protein-coding genes that include a type IV secretion system that is responsible for secreting toxins to assist in virulence. [2]

Metabolism

Helicobacter typhlonius is a microaerophile capable of oxidative phosphorylation using oxygen as a terminal electron acceptor. [6] In this species, fermentation of pyruvate and Acetyl-CoA to acetate is possible in the absence of oxygen. [6] Additionally, carbohydrate breakdown includes both sucrose and mannose and amino-acid degradation includes citrulline, aspartate, glutamate, and glutamine. [6] H. typhlonius is also capable of arginine biosynthesis through the urea cycle. [6]

Ecology

Helicobacter typhlonius can grow at 37 and 42°C, but it cannot be grown at 25°C or in the presence of 1.5% sodium chloride. [1] The typical spiral morphology can also change into cocci when grown in the presence of 1% glycine, but growth rate remains the same. [1] Growth optima of H. typhlonius occur in microaerobic conditions. [1] It is typically found in the gastrointestinal tract of immunodeficient rodents and humans, and is characterized by a 166-base-pair intervening sequence in its 16s rRNA, which has been previously detected by 16s rRNA gene sequence analysis. [1]

Significance

Helicobacter typhlonius is thought to cause irritable bowel syndrome (IBS) in both humans and animals, so it is used to study IBS pathogenesis and treatment. [3] [1] [5] Along with this, some research has linked H. typhlonius with the regulation of intestinal tumors. [4] [7] From studying Apc-mutant mice, researchers were able to use PCR amplification to observe certain segments of DNA and narrow down the cause to two possible bacterial species: Akkermansia muciniphila and H. typhlonius. [7] A positive correlation was established between the prevalence of these bacteria and tumor size. [7] t H. typhlonius has also been found to cause typhlocolitis in immunocompromised mice. [8] Typhlocolitis is characterized by inflammation and necrosis of the mucosal lining in the intestinal tract, specifically cecal, colonic, and small intestinal tissues. [9]

Related Research Articles

<span class="mw-page-title-main">Crohn's disease</span> Type of inflammatory bowel disease

Crohn's disease is a type of inflammatory bowel disease (IBD) that may affect any segment of the gastrointestinal tract. Symptoms often include abdominal pain, diarrhea, fever, abdominal distension, and weight loss. Complications outside of the gastrointestinal tract may include anemia, skin rashes, arthritis, inflammation of the eye, and fatigue. The skin rashes may be due to infections as well as pyoderma gangrenosum or erythema nodosum. Bowel obstruction may occur as a complication of chronic inflammation, and those with the disease are at greater risk of colon cancer and small bowel cancer.

<i>Helicobacter pylori</i> Species of bacteria

Helicobacter pylori, previously known as Campylobacter pylori, is a gram-negative, microaerophilic, spiral (helical) bacterium usually found in the stomach. Its helical shape is thought to have evolved in order to penetrate the mucoid lining of the stomach and thereby establish infection. The bacterium was first identified in 1982 by the Australian doctors Barry Marshall and Robin Warren. H. pylori has been associated with cancer of the mucosa-associated lymphoid tissue in the stomach, esophagus, colon, rectum, or tissues around the eye, and of lymphoid tissue in the stomach.

<i>Helicobacter</i> Genus of bacteria

Helicobacter is a genus of Gram-negative bacteria possessing a characteristic helical shape. They were initially considered to be members of the genus Campylobacter, but in 1989, Goodwin et al. published sufficient reasons to justify the new genus name Helicobacter. The genus Helicobacter contains about 35 species.

<span class="mw-page-title-main">Achlorhydria</span> Medical condition

Achlorhydria and hypochlorhydria refer to states where the production of hydrochloric acid in gastric secretions of the stomach and other digestive organs is absent or low, respectively. It is associated with various other medical problems.

<i>Nla</i>III Enzyme

NlaIII is a type II restriction enzyme isolated from Neisseria lactamica. As part of the restriction modification system, NlaIII is able to prevent foreign DNA from integrating into the host genome by cutting double stranded DNA into fragments at specific sequences. This results in further degradation of the fragmented foreign DNA and prevents it from infecting the host genome.

Chlamydia muridarum is an intracellular bacterial species that at one time belonged to Chlamydia trachomatis. However, C. trachomatis naturally only infects humans and C. muridarum naturally infects only members of the family Muridae.

<span class="mw-page-title-main">Toll-like receptor 5</span> Protein-coding gene in the species Homo sapiens

Toll-like receptor 5, also known as TLR5, is a protein which in humans is encoded by the TLR5 gene. It is a member of the toll-like receptor (TLR) family. TLR5 is known to recognize bacterial flagellin from invading mobile bacteria. It has been shown to be involved in the onset of many diseases, which includes Inflammatory bowel disease. Recent studies have also shown that malfunctioning of TLR5 is likely related to rheumatoid arthritis, osteoclastogenesis, and bone loss. Abnormal TLR5 functioning is related to the onset of gastric, cervical, endometrial and ovarian cancers.

<span class="mw-page-title-main">Formyl peptide receptor 2</span> Protein-coding gene in the species Homo sapiens

N-formyl peptide receptor 2 (FPR2) is a G-protein coupled receptor (GPCR) located on the surface of many cell types of various animal species. The human receptor protein is encoded by the FPR2 gene and is activated to regulate cell function by binding any one of a wide variety of ligands including not only certain N-Formylmethionine-containing oligopeptides such as N-Formylmethionine-leucyl-phenylalanine (FMLP) but also the polyunsaturated fatty acid metabolite of arachidonic acid, lipoxin A4 (LXA4). Because of its interaction with lipoxin A4, FPR2 is also commonly named the ALX/FPR2 or just ALX receptor.

<span class="mw-page-title-main">Peptidoglycan recognition protein 2</span> Protein-coding gene in the species Homo sapiens

Peptidoglycan recognition protein 2(PGLYRP2) is an enzyme, N-acetylmuramoyl-L-alanine amidase (NAMLAA), that hydrolyzes bacterial cell wall peptidoglycan and is encoded by the PGLYRP2 gene.

Mouse models of colorectal cancer and intestinal cancer are experimental systems in which mice are genetically manipulated, fed a modified diet, or challenged with chemicals to develop malignancies in the gastrointestinal tract. These models enable researchers to study the onset, progression of the disease, and understand in depth the molecular events that contribute to the development and spread of colorectal cancer. They also provide a valuable biological system, to simulate human physiological conditions, suitable for testing therapeutics.

Campylobacter concisus is a Gram-negative, highly fastidious, mesophilic bacterium that grows under both anaerobic and microaerobic conditions with the presence of hydrogen significantly aiding growth. Motile, with either unipolar or bipolar flagella, the organisms have a characteristic spiral/corkscrew appearance and are oxidase-positive. Although the human oral cavity is the natural colonization site of the bacterium, C. concisus may also colonize the intestinal tract of some individuals. In particular, several studies have reported higher intestinal prevalence of C. concisus in patients with IBD compared to healthy controls, which has led to current speculation of the bacterium's implication in the induction of Crohn's disease.

Helicobacter hepaticus is a bacterium in the Helicobacteraceae family, Campylobacterales order.

<i>Helicobacter bilis</i> Species of bacterium

Helicobacter bilis is a bacterium in the Helicobacteraceae family, Campylobacterales order. It is a fusiform bacterium with three to 14 multiple bipolar sheathed flagella and periplasmic fibers wrapped around the cell. It is resistant to cephalothin and nalidixic acid, but sensitive to metronidazole. Like Helicobacter hepaticus, it colonizes the bile, liver, and intestine of mice, and is associated with multifocal chronic hepatitis and hepatocellular tumors.

Helicobacter rodentium is a bacterium in the Helicobacteraceae family, Campylobacterales order. It is a spiral-shaped bacterium with a bipolar, single, nonsheathed flagellum. It is resistant to cephalothin and nalidixic acid. Its type strain is MIT 95-1707. Its name refers to the species first being isolated from mice.

Helicobacter muridarum is a bacterium in the Helicobacteraceae family, Campylobacterales order. It is microaerophilic and helical and was first isolated from the intestinal mucosa of rodents, hence its name. It is characterised by the presence of 9 to 11 periplasmic fibers which appear as concentric helical ridges on the surface of each cell. The cells are motile and have bipolar tufts of 10 to 14 sheathed flagella. These bacteria are nutritionally fastidious and physiologically similar to other Helicobacter species and Wolinella succinogenes, but can be differentiated from these organisms by their unique cellular ultrastructure. ST1T is its type strain.

<i>Lacticaseibacillus paracasei</i> Species of bacterium

Lacticaseibacillus paracasei is a gram-positive, homofermentative species of lactic acid bacteria that are commonly used in dairy product fermentation and as probiotic cultures. Lc. paracasei is a bacterium that operates by commensalism. It is commonly found in many human habitats such as human intestinal tracts and mouths as well as sewages, silages, and previously mentioned dairy products. The name includes morphology, a rod-shaped bacterium with a width of 2.0 to 4.0μm and length of 0.8 to 1.0μm.

<i>Akkermansia muciniphila</i> Species of bacterium

Akkermansia muciniphila is a human intestinal symbiont, isolated from human feces. It is a mucin-degrading bacterium belonging to the genus, Akkermansia, discovered in 2004 by Muriel Derrien and Willem de Vos at Wageningen University of the Netherlands. It belongs to the phylum Verrucomicrobiota and its type strain is MucT. It is under preliminary research for its potential association with metabolic disorders.

The altered Schaedler flora (ASF) is a community of eight bacterial species: two lactobacilli, one Bacteroides, one spiral bacterium of the Flexistipes genus, and four extremely oxygen sensitive (EOS) fusiform-shaped species. The bacteria are selected for their dominance and persistence in the normal microflora of mice, and for their ability to be isolated and grown in laboratory settings. Germ-free animals, mainly mice, are colonized with ASF for the purpose of studying the gastrointestinal (GI) tract. Intestinal mutualistic bacteria play an important role in affecting gene expression of the GI tract, immune responses, nutrient absorption, and pathogen resistance. The standardized microbial cocktail enabled the controlled study of microbe and host interactions, role of microbes, pathogen effects, and intestinal immunity and disease association, such as cancer, inflammatory bowel disease, diabetes, and other inflammatory or autoimmune diseases. Also, compared to germfree animals, ASF mice have fully developed immune system, resistance to opportunistic pathogens, and normal GI function and health, and are a great representation of normal mice.

Akkermansia glycanphila is a species of intestinal mucin-degrading bacterium. It was first isolated from reticulated python feces in 2016.

Helicobacter cetorum is a Gram-negative, microaerophilic, spiral (helical) bacterium that is usually found in the stomachs of whales and dolphins. Based on 16S rRNA sequencing, its genome is very similar to that of Helicobacter pylori in that it can cause gastric disease in these animals. Originally isolated among Atlantic white-sided dolphins and Beluga whales in 2000, H. cetorum has been associated with hemorrhages throughout its entire gastrointestinal tract, but its role has not yet been discovered. Prior to the discovery of H. cetorum, there have not been any other Helicobacter species reported in dolphins.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Franklin CL, Gorelick PL, Riley LK, Dewhirst FE, Livingston RS, Ward JM, Beckwith CS, Fox JG (November 2001). "Helicobacter typhlonius sp. nov., a Novel Murine Urease-Negative Helicobacter Species". Journal of Clinical Microbiology. 39 (11): 3920–6. doi:10.1128/JCM.39.11.3920-3926.2001. PMC   88465 . PMID   11682508.
  2. 1 2 3 4 5 6 7 8 9 10 Frank J, Dingemanse C, Schmitz AM, Vossen RH, van Ommen GJ, den Dunnen JT, Robanus-Maandag EC, Anvar SY (2016-01-08). "The Complete Genome Sequence of the Murine Pathobiont Helicobacter typhlonius". Frontiers in Microbiology. 6: 1549. doi: 10.3389/fmicb.2015.01549 . PMC   4705304 . PMID   26779178.
  3. 1 2 Chichlowski M, Sharp JM, Vanderford DA, Myles MH, Hale LP (December 2008). "Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice". Comparative Medicine. 58 (6): 534–41. PMC   2710754 . PMID   19149410.
  4. 1 2 Chichlowski, Maciej; Hale, Laura P (2009-02-15). "Effects of Helicobacter Infection on Research: The Case for Eradication of Helicobacter from Rodent Research Colonies". Comparative Medicine. 59 (1): 10–17. PMC   2703140 . PMID   19295050.
  5. 1 2 Scavizzi F, Raspa M (January 2006). "Helicobacter typhlonius was detected in the sex organs of three mouse strains but did not transmit vertically". Laboratory Animals. 40 (1): 70–9. doi:10.1258/002367706775404390. PMID   16460591. S2CID   9941560.
  6. 1 2 3 4 Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K (January 2017). "KEGG: new perspectives on genomes, pathways, diseases and drugs". Nucleic Acids Research. 45 (D1): D353–D361. doi:10.1093/nar/gkw1092. PMC   5210567 . PMID   27899662.
  7. 1 2 3 Dingemanse C, Belzer C, van Hijum SA, Günthel M, Salvatori D, den Dunnen JT, Kuijper EJ, Devilee P, de Vos WM, van Ommen GB, Robanus-Maandag EC (November 2015). "Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice". Carcinogenesis. 36 (11): 1388–96. doi: 10.1093/carcin/bgv120 . PMID   26320104.
  8. ↑ Taylor NS, Xu S, Nambiar P, Dewhirst FE, Fox JG (July 2007). "Enterohepatic Helicobacter species are prevalent in mice from commercial and academic institutions in Asia, Europe, and North America". Journal of Clinical Microbiology. 45 (7): 2166–72. doi:10.1128/JCM.00137-07. PMC   1933014 . PMID   17507523.
  9. ↑ Barthold, SW; Smith, AL; Lord, PF; Bhatt, PN; Jacoby, RO; Main, AJ (August 1, 1982). "Epizootic coronaviral typhlocolitis in suckling mice". Laboratory Animal Science. 32 (4): 376–83. ISSN   0023-6764. PMID   6292575.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.